Octave Bioscience Stock

Company Profile:

Octave Bioscience offers a pioneering bloodâ€based diagnostic test that measures multiple biomarkers to assess disease activity in multiple sclerosis. Octave Bioscience delivers personalized neurodegenerative disease insights that help guide clinical treatment decisions.

Sign up for SecondMarket® to view the market and buy or sell Octave Bioscience Stock

Buy + Sell

Leverage Your Equity to Help Achieve More.

Octave Bioscience Funding

Sign up to gain insights into Octave Bioscience funding history, including the funding round, time period, and amount raised.

Financing Round	Date	Amount	Price per share*	Valuation*
Series B	Sep 04, 2025	3.76M	Price	Valuation
Series B	Mar 07, 2025	31.84M	Price	Valuation
Series B	Jan 04, 2023	32.25M	Price	Valuation
Series B	Oct 29, 2020	30.00M	Price	Valuation
Series A	Jul 12, 2018	14.00M	Price	Valuation
Series Seed	Dec 20, 2016	2.50M	Price	Valuation

*Access the PPS, Valuation details, and a wealth of other data by signing up. Source: Nasdaq Private Market Tape D®

See Octave Bioscience Valuations + Financials

*Sample data + company shown for illustrative purposes only

Gain insights Into Octave Bioscience Stock Valuation + Share Prices

View real-time Tape D® data on Octave Bioscience stock including most recent valuation and historical share price information.

Are you an institutional investor or employee shareholder? Sign up to the SecondMarket trading platform.

Get Started

Leverage Your Equity to Help Achieve More.

Octave Bioscience Management Team

Board Member

Grant Heidrich
Board Member

Brook Byers
Board Member

George Scangos
Co-Founder, COO

Melinda Thomas
CEO, Board Member

William A. Hagstrom
Chief Commercial Officer

Maital Shemesh-Rasmussen
Board Member

Thomas C. Hawes
Board Member

Michael J. Pellini
Board Member

Andrea Jackson
CTO

Erwan Rivet

Octave Bioscience Major Investors

Merck Global Health Innovation Fund
Section 32
Blue Venture Fund
Deerfield Management Company
Echo Health Ventures
Northpond Ventures
BlueCross BlueShield Venture Partners
S32
Intermountain Ventures
Valhalla Charitable Foundation
Hikma Ventures
Novartis
Byers Capital
Casdin Capital

Learn More About Octave Bioscience Stock

Buy Octave Bioscience Stock

Octave Bioscience stock does not trade on public stock exchanges. Octave Bioscience stock is considered a private security and you need to be an accredited investor to trade shares. To invest in Octave Bioscience stock you can either buy shares directly through the company or work with a secondary trading marketplace like Nasdaq Private Market.

Learn more about the secondary market for private company shares on the investors page.

Sell Octave Bioscience Stock

Octave Bioscience Stock does not trade on public stock exchanges. In order to sell Octave Bioscience shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.

Learn more about NPM services for selling privately held stock on the Employee Shareholders page.

Read more about how to sell private company stock on the private secondary market:

Octave Bioscience Stock Price

Octave Bioscience does not have a publicly available stock price because it is privately held and not traded on public stock exchanges. Through the Tape D™ database from Nasdaq Private Market, you can view Octave Bioscience share price and other valuable private market data.

Read more about secondary market private company stock prices:

Understanding the Bid-Ask Spread: How Buyers and Sellers Match on Price

Octave Bioscience Stock Ticker Symbol

There is no ticker symbol for Octave Bioscience stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company ‘street’ name or legal name.

Criteria to Sell Octave Bioscience Stock

Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell Octave Bioscience stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.

Learn more about selling privately held stock on the Employee Shareholders page.

Read more about how to sell shares of a private company and eligibility for selling privately held stock:

Are You Eligible to Sell Private Company Stock?

Criteria to Buy or Invest in Octave Bioscience Stock

Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock. In order to invest in Octave Bioscience stock, you need to be an accredited entity or institutional investor.

Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.

Octave Bioscience Stock Settlement

Once you buy or sell, stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.

To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.

Octave Bioscience IPO

Octave Bioscience is a private company and has not had an IPO. There is currently no Octave Bioscience IPO price. Get started to begin exploring the Nasdaq Private Market Tape D™ database and gain access to actionable data related to Octave Bioscience IPO.

Learn more about Tape D™ private company stock data for institutional investors on the on the Tape D™ Product Page.

Sign up for SecondMarket® to view the market and buy or sell Octave Bioscience Stock

Buy + Sell

*All trademarks are the property of their respective owner(s). Unless expressly stated otherwise, companies listed on this site are not sponsoring, endorsing, or otherwise affiliated with, Nasdaq Private Market, LLC, and none of the statements on this website should be attributed to a listed company.